ERBB2 and triple-negative breast carcinoma: In addition, we found that low membranous HER3 protein expression was associated with an aggressive triple-negative breast cancer (TNBC) phenotype (p = 0.000), defined as concurrently negative ER, PR, and HER2 statuses.